RTFCCR-MRA Team Science Awards on Improving the Early Detection, Diagnosis, and Risk of Melanoma Stratification Grant

RTFCCR-MRA Team Science Awards on Improving the Early Detection, Diagnosis, and Risk of Melanoma Stratification Grant

Status: ACTIVE
Funder: Melanoma Research Alliance Foundation
Amount: Up to US $900,000
Last Updated: December 06, 2025

Summary

The RTFCCR-MRA Team Science Awards aim to enhance early detection and diagnosis of melanoma through patient-engaged clinical validation studies or pilot trials. These awards prioritize innovative methods with supporting preliminary data, fostering collaboration between researchers and patient partners in the research process. By addressing significant unmet needs in melanoma care, this funding opportunity invites diverse research groups to develop effective detection and risk stratification strategies for melanoma, ultimately improving patient outcomes.

Overview

RTFCCR-MRA Team Science Awards on Melanoma Early Detection, Diagnosis, and Risk Stratification The MRA and RTFCCR will jointly support a Team Science Award for clinical validation studies or pilot (phase I) clinical trials aimed at improving melanoma early detection, diagnosis, and risk stratification. Patient involvement must be actively demonstrated throughout the full life cycle of the work, including planning and dissemination. We define patient involvement as meaningful engagement of patient partners in the development of therapeutic, detection, or prevention approaches to cancer care. It encompasses the active and collaborative interaction between patient partners and researchers across all stages of the research process from conception to results distribution, where research decision making is supported by patient partners’ contributions, recognizing their specific experiences, values, and expertise. These awards will support innovative approaches with preliminary data, where funding is required to advance the validation of tests, technologies, or devices. We welcome applications from all research groups with a track record in melanoma. Grant applicants should actively involve patient partners in the protocol design. Purpose: RTFCCR and MRA have identified early detection and accurate diagnosis of melanoma and the identification of high-risk patients whose primary tumors are most likely to progress as significant areas of unmet need. The purpose of this call for proposals is to solicit high quality research proposals focused on improving the early detection, diagnosis, and risk stratification of melanoma.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.